Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center Identifier:
First received: May 18, 2008
Last updated: March 7, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)